Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 1-2, 2013, Pages 202-210

  Paszko, Edyta ^a   Vaz, Gisela M F ^a   Ehrhardt, Carsten ^b   Senge, Mathias O ^a,b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytotoxicity; Drug targeting; Encapsulation; High content analysis; mTHPC

Indexed keywords

5,10,15,20 TETRA(3 HYDROXYHYDROXYPHENYL)CHLORIN; LIPOSOMAL FOSCAN; LIPOSOME; MACROGOL; PHOTOSENSITIZING AGENT; TEMOPORFIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTENT ANALYSIS; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PHOTOCYTOTOXICITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; HUMANS; LIPOSOMES; MESOPORPHYRINS; PHOSPHATIDYLGLYCEROLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 84870381703     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.10.018     Document Type: Article

References (48)

1. S. Anabousi, M. Laue, C.M. Lehr, U. Bakowsky, and C. Ehrhardt Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy Eur. J. Pharm. Biopharm. 60 2005 295 303
2. S. Anabousi, U. Bakowsky, M. Schneider, H. Huwer, C.M. Lehr, and C. Ehrhardt In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer Eur. J. Pharm. Sci. 29 2006 367 374
3. H. Bakowsky, T. Richter, C. Kneuer, D. Hoekstra, U. Rothe, C. Ehrhardt, and U. Bakowsky Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery Biochim. Biophys. Acta-Biomembranes 1778 2008 242 249
4. M.C. Berenbaum, and R. Bonnett The search for tumour-photosensitizing porphyrins J. Pathol. 138 1982 80
5. R. Bonnett, R.D. White, U.J. Winfield, and M.C. Berenbaum Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers Biochem. J. 261 1989 277 280
6. J. Boult, K. Roberts, M.J. Brookes, S. Hughes, J.P. Bury, S.S. Cross, G.J. Anderson, R. Spychal, T. Iqbal, and C. Tselepis Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma Clin. Cancer Res. 14 2008 379 387
7. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechnisms in photodynamic therapy: part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction Photodiagn. Photodyn. Ther. 2 2004 91 106
8. T.R. Daniels, T. Delgado, G. Helguera, and M.L. Penichet The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells Clin. Immunol. 121 2006 159 176
9. A.S. Derycke, and P.A. de Witte Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes Int. J. Oncol. 20 2002 181 187
10. A.S. Derycke, A. Kamuhabwa, A. Gijsens, T. Roskams, D. De Vos, A. Kasran, J. Huwyler, L. Missiaen, and P.A. de Witte Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells J. Natl Cancer Inst. 96 2004 1620 1630
11. G.W. Falk Gastroesophageal reflux disease and Barrett's esophagus Endoscopy 33 2001 109 118
12. Feest, C.; 2009. Photophysical characterization and in vitro testing of novel tetraphenylporphyrin derivative with respect to their application in photodynamic therapy. Diploma thesis, Humboldt-Universität Berlin.
13. M. Gaspar, A. Radomska, O.L. Gobbo, U. Bakowsky, M.W. Radomski, and C. Ehrhardt Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats J. Aerosol Med. Pulm. Drug Deliv. 2012 10.1089/jamp. 2011.0928
14. A. Gijsens, A. Derycke, L. Missiaen, D. De Vos, J. Huwyler, A. Eberle, and P. de Witte Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes Int. J. Cancer 101 2002 78 85
15. J. Haringsma Barrett's oesophagus: new diagnostic and therapeutic techniques Scand. J. Gastroenterol. Suppl. 236 2002 9 14
16. H. Hatakeyama, H. Akita, K. Maruyama, T. Suhara, and H. Harashima Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 281 2004 25 33
17. H. Hefesha, S. Loew, X. Liu, S. May, and A. Fahr Transfer mechanism of temoporfin between liposomal membranes J. Control. Release 150 2011 279 286
18. O. Ishida, K. Maruyama, H. Tanakashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, and H. Yanagie Liposomes bearing polyethyleneglycol coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 2001 1042 1048
19. B. Javaid, P. Watt, and N. Krasner Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study Lasers Med. Sci. 17 2002 51 56
20. C.J. Kelty, S.L. Marcus, and R. Ackroyd Photodynamic therapy for Barrett's esophagus: a review Dis. Esophagus 15 2002 137 144
21. M. Kepczyński, K. Nawalany, B. Jachimska, M. Romek, and M. Nowakowska Pegylated tetraarylporphyrin entrapped in liposomal membranes. A possible novel drug-carrier system for photodynamic therapy Colloids. Surf. B Biointerfaces. 49 2006 22 30
22. D. Kessel, and T.J. Dougherty Agents used in photodynamic therapy Rev. Contemp. Pharmacother. 10 1999 19 24
23. J. Kuntsche, I. Freisleben, F. Steiniger, and A. Fahr Temoporfin-loaded liposomes: physicochemical characterization Eur. J. Pharm. Sci. 40 2010 305 315
24. W.N. Leung, X. Sun, N.K. Mak, and C.M. Yow Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis Photochem. Photobiol. 75 2002 406 411
25. X. Li, L. Ding, Y. Xu, Y. Wang, and Q. Ping Targeted delivery of doxorubicin using stealth liposomes modified with transferrin Int. J. Pharm. 373 2009 116 123
26. L.A. Lopez-Barcons, D. Polo, A. Llorens, F. Reig, and A. Fabra Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio Oncol. Rep. 14 2005 1337 1343
27. L.B. Lovat, N.F. Jamieson, M.R. Novelli, C.A. Mosse, C. Selvasekar, G.D. Mackenzie, S.M. Thorpe, and S.G. Bown Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus Gastrointest. Endosc. 62 2005 617 623
28. I.J. MacDonald, and T.J. Dougherty Basic principles of photodynamic therapy J. Porphyrins Phthalocyanines 5 2001 105 129
29. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and EPR effect in macromolecular therapeutics-a review J. Control. Release 65 2000 271 284
30. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
31. E.S. Nyman, and P.H. Hynninen Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy J. Photochem. Photobiol. B: Biol. 73 2004 1 28
32. R.K. Pandey, and G. Zheng Porphyrins as photosensitizers in photodynamic therapy K.M. Kadish, R. Guilard, K.M. Smith, The Porphyrin Handbook vol. 6 2000 Academic Press New York 157 230
33. E. Paszko, C. Ehrhardt, M.O. Senge, D.P. Kelleher, and J.V. Reynolds Nanodrug application in photodynamic therapy Photodiagn. Photodyn. Ther. 8 2011 14 29
34. K. Plaetzer, B. Krammer, J. Berlanda, F. Berr, and T. Kiesslich Photophysics and photochemistry of photodynamic therapy: fundamental aspects Lasers Med. Sci. 24 2009 259 268
35. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J. Natl Cancer Inst. 97 2005 142 146
36. N. Sakaguchi, C. Kojima, A. Harada, K. Koiwai, N. Emi, and K. Kono Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes Bioconjug. Chem. 19 2008 1588 1595
37. M.O. Senge mTHPC-a drug on its way from second to third generation photosensitizer Photodiagn. Photodyn. Ther. 9 2012 170 179
38. M.O. Senge, and J.C. Brandt Temoporfin (Foscan®, 5,10,15,20-tetra(m- hydroxyphenyl)chlorin)-a second generation photosensitizer Photochem. Photobiol. 87 2011 1240 1296
39. M. Singh Transferrin as a targeting ligand for liposomes and anticancer drugs Curr. Pharm. Des. 5 1999 443 451
40. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
41. J.C. Stewart Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal. Biochem. 104 1980 10 14
42. M. Tim Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
43. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
44. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555
45. V.P. Torchilin Targeted pharmaceutical nanocarriers for cancer therapy and imaging AAPS J. 9 2007 E128 E147
46. J. van Renswoude, K.R. Bridges, J.B. Harford, and R.D. Klausner Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment Proc. Natl. Acad. Sci. USA 79 1982 6186 6190
47. I. van Rooy, E. Mastrobattista, G. Storm, W.E. Hennink, and R.M. Schiffelers Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain J. Control Release 150 2011 30 36
48. J. Wu, Y. Lu, A. Lee, X. Pan, X. Yang, X. Zhao, and R.J. Lee Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil J. Pharm. Pharm. Sci. 10 2007 350 357